CareRay Digital Medical Technology Co., Ltd. (SHA:688607)
China · Delayed Price · Currency is CNY 63.46
-1.14 (-1.76%)
May 21, 2026, 3:00 PM CST
SHA:688607 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 316.84 | 306.74 | 288.88 | 267.68 | 197.4 | 328.05 |
Other Revenue | 14.12 | 14.12 | 9.22 | 6.06 | 7.18 | 13.93 |
| 330.96 | 320.86 | 298.1 | 273.74 | 204.57 | 341.98 | |
Revenue Growth (YoY) | 9.02% | 7.63% | 8.90% | 33.81% | -40.18% | 0.81% |
Cost of Revenue | 217.55 | 210.81 | 185.59 | 172.69 | 140.88 | 185.19 |
Gross Profit | 113.41 | 110.05 | 112.51 | 101.05 | 63.69 | 156.79 |
Selling, General & Admin | 77.23 | 68.36 | 58.18 | 54.96 | 52.91 | 46.5 |
Research & Development | 34.22 | 32.05 | 43.72 | 44.6 | 44.52 | 31.87 |
Other Operating Expenses | -1.52 | -1.64 | -0.58 | -0.44 | -0.58 | -1.57 |
Operating Expenses | 126.41 | 116.11 | 103.87 | 100.5 | 97.2 | 80.6 |
Operating Income | -13 | -6.06 | 8.63 | 0.56 | -33.51 | 76.19 |
Interest Expense | -0.78 | -0.95 | -0.75 | -0.51 | -0.37 | -0.21 |
Interest & Investment Income | 1.46 | 1.62 | 8.01 | 10.22 | 12.51 | 18.9 |
Currency Exchange Gain (Loss) | -7.17 | -7.17 | 1.04 | 2.97 | 10.27 | -1.26 |
Other Non Operating Income (Expenses) | -7.5 | -0.41 | 1.06 | -1.12 | -0.55 | -0.44 |
EBT Excluding Unusual Items | -26.98 | -12.96 | 17.99 | 12.12 | -11.65 | 93.17 |
Gain (Loss) on Sale of Investments | 1.74 | 2.25 | -1.15 | 1.41 | 0.11 | -0.34 |
Gain (Loss) on Sale of Assets | 0.14 | 0.15 | -0 | 0.19 | -0.04 | - |
Asset Writedown | -0.28 | -0.12 | -0.02 | - | - | - |
Legal Settlements | - | - | -0.01 | - | - | - |
Other Unusual Items | 1.04 | 1.2 | 0.87 | 1.58 | 2.67 | 3.44 |
Pretax Income | -24.34 | -9.48 | 17.69 | 15.3 | -8.91 | 96.28 |
Income Tax Expense | -3.33 | -2.16 | 0.01 | -0.11 | -3.23 | 11.23 |
Earnings From Continuing Operations | -21.02 | -7.33 | 17.68 | 15.41 | -5.68 | 85.05 |
Minority Interest in Earnings | 1.43 | 0.66 | -0.02 | 0 | 0.05 | 0.04 |
Net Income | -19.59 | -6.67 | 17.65 | 15.41 | -5.63 | 85.09 |
Net Income to Common | -19.59 | -6.67 | 17.65 | 15.41 | -5.63 | 85.09 |
Net Income Growth | - | - | 14.54% | - | - | 13.23% |
Shares Outstanding (Basic) | 84 | 83 | 88 | 91 | 94 | 86 |
Shares Outstanding (Diluted) | 84 | 83 | 88 | 91 | 94 | 86 |
Shares Change (YoY) | 5.78% | -5.58% | -2.64% | -3.38% | 9.18% | 30.39% |
EPS (Basic) | -0.23 | -0.08 | 0.20 | 0.17 | -0.06 | 0.99 |
EPS (Diluted) | -0.23 | -0.08 | 0.20 | 0.17 | -0.06 | 0.99 |
EPS Growth | - | - | 17.65% | - | - | -13.16% |
Free Cash Flow | -115.16 | -138.44 | -73.59 | -21.71 | -55.89 | 17.46 |
Free Cash Flow Per Share | -1.37 | -1.66 | -0.83 | -0.24 | -0.60 | 0.20 |
Dividend Per Share | - | - | 0.061 | 0.054 | - | - |
Dividend Growth | - | - | 12.96% | - | - | - |
Gross Margin | 34.27% | 34.30% | 37.74% | 36.92% | 31.13% | 45.85% |
Operating Margin | -3.93% | -1.89% | 2.90% | 0.20% | -16.38% | 22.28% |
Profit Margin | -5.92% | -2.08% | 5.92% | 5.63% | -2.75% | 24.88% |
Free Cash Flow Margin | -34.80% | -43.15% | -24.69% | -7.93% | -27.32% | 5.11% |
EBITDA | -10.02 | -3.09 | 11.54 | 6.71 | -27 | 82.3 |
EBITDA Margin | -3.03% | -0.96% | 3.87% | 2.45% | -13.20% | 24.06% |
D&A For EBITDA | 2.98 | 2.97 | 2.9 | 6.15 | 6.51 | 6.11 |
EBIT | -13 | -6.06 | 8.63 | 0.56 | -33.51 | 76.19 |
EBIT Margin | -3.93% | -1.89% | 2.90% | 0.20% | -16.38% | 22.28% |
Effective Tax Rate | - | - | 0.06% | - | - | 11.66% |
Revenue as Reported | 330.96 | 320.86 | 298.1 | 273.74 | 204.57 | 341.98 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.